SC
ONEM

Sagefield Capital’s 1Life Healthcare ONEM Stock Holding History

Sagefield Capital’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,600
Closed -$216K – 112
2022
Q3 		$216K Buy
+12,600
New +$198K 0.07% 108

Other funds holding ONEM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Sagefield Capital's ONEM Position: Q4 2022 in Review

Sagefield Capital sold out of 1Life Healthcare (ONEM) in Q4 2022, closing a stake of 12,600 shares — an estimated $216K sold.

Sagefield Capital first reported a position in ONEM in Q3 2022 and held it in 1 quarter. The position peaked at $216K in Q3 2022. 230 funds tracked by Wall St. Rank hold ONEM as of Q4 2022.

  • Sagefield Capital reported no remaining 1Life Healthcare position as of Q4 2022 after selling out during the quarter.
  • Sagefield Capital sold 12,600 1Life Healthcare shares in Q4 2022, an estimated $216K.
  • Sagefield Capital first reported a position in 1Life Healthcare in Q3 2022 and held it in 1 quarter.
  • Sagefield Capital's 1Life Healthcare position peaked at $216K in Q3 2022.
  • 230 funds tracked by Wall St. Rank held 1Life Healthcare as of Q4 2022.

Based on Sagefield Capital's 13F filing for Q4 2022, filed 14 Feb 2023.